EuroPCR 2026 – Prof Bruno Scheller (Saarland University Hospital, Homburg, DE) joins us to explore the evolving role of drug-coated balloons in coronary intervention, discussing the latest trial evidence and how it is shaping clinical practice.

Interview Questions:

1. How has the role of DCBs in coronary intervention evolved over recent years?
2. What does the latest trial evidence add to our understanding of DCB efficacy and safety?
3. How should clinicians approach patient and lesion selection for a DCB strategy?
4. In which scenarios do DCBs now represent a preferred alternative to DES?
5. What are your key take-home messages for interventionalists considering DCBs in routine practice?

Recorded on-site at EuroPCR 2026, Paris.
Editors: Jordan Rance
Videographer: Dan Brent
Support: This is an independent interview produced by Radcliffe Cardiology.